Cite
HARVARD Citation
Yalcin, A. et al. (n.d.). Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels. Expert opinion on biological therapy. pp. 1335-1341. [Online].